Monte Rosa Therapeutics, Inc. GLUE NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

66/100

5/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Monte Rosa Therapeutics, Inc. (GLUE), dont 29 achats et 20 ventes. Le total des achats d'initiés s'élève à $8.8M et le total des ventes d'initiés à $11.95M.

Les initiés notables ayant une activité récente comprennent Dunn Edmund, Warmuth Markus, Janku Filip. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — GLUE

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-03-04	Dunn Edmund	Principal Accounting Officer	Vente Informative	139	$17.96	$2.5K	22,554
2026-03-02	Dunn Edmund	Principal Accounting Officer	Exercice d'Options (Vente)	536	$13.41	$7.19K	-
2026-03-02	Warmuth Markus	President & CEO	Vente Informative	5,466	$17.92	$97.97K	613,471
2026-02-27	Dunn Edmund	Principal Accounting Officer	Exercice d'Options (Vente)	25,164	$13.41	$337.45K	536
2026-02-23	Janku Filip	Chief Medical Officer	Vente Informative	9,189	$19.50	$179.16K	65,837
2026-01-07	Warmuth Markus	President & CEO	Vente Informative	309	$24.57	$7.59K	618,937
2026-01-05	Warmuth Markus	President & CEO	Vente Informative	10,135	$15.17	$153.75K	624,403
2026-01-05	Townson Sharon	Chief Scientific Officer	Vente Informative	3,155	$15.17	$47.86K	67,845
2026-01-05	Janku Filip	Chief Medical Officer	Vente Informative	3,155	$15.17	$47.86K	75,026
2026-01-05	Nickson Philip	Chief Business & Legal Officer	Vente Informative	3,155	$15.17	$47.86K	60,845
2026-01-05	Dunn Edmund	Principal Accounting Officer	Vente Informative	1,039	$15.17	$15.76K	22,693
2026-01-05	Champoux Jennifer	Chief Operating Officer	Vente Informative	2,629	$15.17	$39.88K	62,371
2026-01-02	Warmuth Markus	President & CEO	Attribution de RSU	406,000	$15.31	$6.22M	406,000
2026-01-02	Townson Sharon	Chief Scientific Officer	Attribution de RSU	35,000	-	-	71,000
2026-01-02	Janku Filip	Chief Medical Officer	Attribution de RSU	31,000	-	-	78,181
2026-01-02	Nickson Philip	Chief Business & Legal Officer	Attribution de RSU	28,000	-	-	64,000
2026-01-02	Champoux Jennifer	Chief Operating Officer	Attribution de RSU	35,000	-	-	65,000
2025-06-13	Schiff Andrew N	Director	Attribution de RSU	30,700	$4.91	$150.74K	30,700
2025-06-13	Behbahani Ali	10 Percent Owner	Attribution de RSU	30,700	$4.91	$150.74K	30,700
2025-06-13	Manning Anthony M.	Director	Attribution de RSU	30,700	$4.91	$150.74K	30,700
2025-06-13	Siu Christine	Director	Attribution de RSU	30,700	$4.91	$150.74K	30,700
2025-06-13	Blackwell Kimberly	Director	Attribution de RSU	30,700	$4.91	$150.74K	30,700
2025-06-13	Skvarka Jan	Director	Attribution de RSU	30,700	$4.91	$150.74K	30,700
2025-06-13	Hughes Eric A	Director	Attribution de RSU	30,700	$4.91	$150.74K	30,700
2025-06-03	Dunn Edmund	Principal Accounting Officer	Vente Informative	2,062	$4.45	$9.17K	23,732
2025-03-24	Leo Chandra P.	Director	Achat Informatif	10,000	$5.84	$58.38K	10,000
2025-01-02	Warmuth Markus	President & CEO	Attribution de RSU	128,000	-	-	544,538
2025-01-02	Townson Sharon	Chief Scientific Officer	Attribution de RSU	36,000	-	-	36,000
2025-01-02	Janku Filip	Chief Medical Officer	Attribution de RSU	36,000	-	-	45,189
2025-01-02	Nickson Philip	Chief Business & Legal Officer	Attribution de RSU	36,000	-	-	36,000
2025-01-02	Dunn Edmund	Principal Accounting Officer	Attribution de RSU	11,850	-	-	25,794
2025-01-02	Champoux Jennifer	Chief Operating Officer	Attribution de RSU	30,000	-	-	30,000
2024-12-11	Hughes Eric A	Officer	Inconnu	-	-	-	-
2024-12-11	Hughes Eric A	Director	Attribution de RSU	44,200	$8.51	$376.14K	44,200
2024-10-29	Versant Venture Capital Vi, L.p.	10 Percent Owner	Vente Informative	15,600	$9.41	$146.79K	1,573,453
2024-10-28	Versant Venture Capital Vi, L.p.	10 Percent Owner	Autre (Vente)	5,454	-	-	-
2024-09-20	Versant Venture Capital Vi, L.p.	10 Percent Owner	Vente Informative	1,132,566	$6.53	$7.4M	5,099,336
2024-09-13	Versant Venture Capital Vi, L.p.	10 Percent Owner	Vente Informative	9,269	$6.16	$57.1K	6,231,902
2024-09-13	Janku Filip	Chief Medical Officer	Attribution de RSU	30,000	$7.56	$226.8K	30,000
2024-09-12	Versant Venture Capital Vi, L.p.	10 Percent Owner	Vente Informative	16,047	$6.00	$96.31K	6,241,171
2024-09-11	Versant Venture Capital Vi, L.p.	10 Percent Owner	Vente Informative	541,897	$6.00	$3.25M	6,257,218
2024-07-05	Dunn Edmund	Principal Accounting Officer	Vente Informative	1,610	$3.83	$6.17K	13,944
2024-06-12	Schiff Andrew N	Director	Attribution de RSU	22,100	$4.16	$91.94K	22,100
2024-06-12	Behbahani Ali	10 Percent Owner	Attribution de RSU	22,100	$4.16	$91.94K	22,100
2024-06-12	Manning Anthony M.	Director	Attribution de RSU	22,100	$4.16	$91.94K	22,100
2024-06-12	Siu Christine	Director	Attribution de RSU	22,100	$4.16	$91.94K	22,100
2024-06-12	Blackwell Kimberly	Director	Attribution de RSU	22,100	$4.16	$91.94K	22,100
2024-06-12	Skvarka Jan	Director	Attribution de RSU	22,100	$4.16	$91.94K	22,100
2024-06-03	Townson Sharon	Chief Scientific Officer	Attribution de RSU	40,000	$3.98	$159.2K	40,000
2024-06-03	Nickson Philip	Chief Business & Legal Officer	Attribution de RSU	40,000	$3.98	$159.2K	40,000

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration